+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
All Ages
All Genders
ID06401083

Study of Additional Caffeine Citrate Dose Before Extubation in Preterm Babies Born Before 32 Weeks

Led by Semmelweis University · Updated on 2024-05-06

226

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether giving a single additional loading dose of caffeine citrate one hour before extubation improves the success rate of extubation in preterm infants born before the 32nd week of gestation. The study also aims to evaluate how this intervention affects the frequency of apnea episodes, side effects, and the development of complications such as necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, and long-term neurodevelopmental outcomes. Participants include preterm neonates who have been mechanically ventilated for at least 48 hours before a planned extubation. They will be randomly assigned to one of two groups one will receive an additional intravenous loading dose of 20 mgkg caffeine citrate 60 minutes before extubation, while the other group will continue with the standard caffeine dosing regimen, which includes a loading dose on the first day of life and a maintenance dose of 5-10 mgkg daily. The trial will be conducted in neonatal intensive care units and includes careful stratification by gestational age and antenatal steroid use. During the study, researchers will monitor the need for reintubation within 48 hours after extubation as the primary outcome. They will also track secondary outcomes such as apnea frequency, heart rate changes, tachycardia, gastric residual volume, feeding reduction, blood pressure changes, days on mechanical or non-invasive ventilation, and rates of common complications in prematurity up to discharge or specific timepoints. Long-term neurodevelopmental outcomes will be assessed at two years of corrected age. Safety and side effects will be carefully observed throughout the study period.

CONDITIONS

Brief Title

The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate

Research Team

K

Kinga Kovács, MD.

Á

Ákos Gasparics, MD.PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here